Rational design of protein kinase inhibitors

von Yarmoluk, S.M., Nyporko, A.Yu., Bdzhola, V.G.
Veröffentlicht 2013

Evaluation of 4H-4-chromenone derivatives as inhibitors of protein kinase CK2

von Prykhodko, A.O., Yakovenko, O.Ya., Golub, A.G., Bdzhola, V.G., Yarmoluk, S.M.
Veröffentlicht 2005

Hit identification of FGFR1 inhibitors using receptor-based virtual screening

von Tarnavskiy, S.S., Protopopov, M.V., Borovykov, O.V., Pryhodko, A.O., Bdzhola, V.G., Yarmoluk, S.M.
Veröffentlicht 2019

Synthesis and biological evaluation of novel amino-substituted derivatives of pyrido[2,3-d]pyrimidine as inhibitors of protein kinase CK2

von Zinchenko, A.N., Muzychka, L.V., Smolii, O.B., Bdzhola, V.G., Protopopov, M.V., Yarmoluk, S.M.
Veröffentlicht 2017

Hit identification of CK2 inhibitors by virtual screening

von Protopopov, M.V., Starosyla, S.A., Borovykov, O.V., Sapelkin, V.N., Bilokin, Y.V., Bdzhola, V.G., Yarmoluk, S.M.
Veröffentlicht 2017

Identification of 4‐methoxythieno[2,3‐d]pyrimidines as FGFR1 Inhibitors

von Kotey, I.M., Protopopov, M.V., Starosyla, S.A., Balanda, A.O., Pletnova, L.V., Prykhod'ko, A.O., Bdzhola, V.G., Yarmoluk, S.M.
Veröffentlicht 2019